MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $41,282,000 | +141.8% | 598,362 | +199.4% | 0.02% | +137.5% |
| Q1 2022 | $17,071,000 | +1161.7% | 199,882 | +2478.1% | 0.01% | +700.0% |
| Q3 2021 | $1,353,000 | -91.1% | 7,753 | -91.7% | 0.00% | -87.5% |
| Q2 2021 | $15,220,000 | +3822.7% | 93,005 | +3900.2% | 0.01% | – |
| Q1 2021 | $388,000 | -73.7% | 2,325 | -67.0% | 0.00% | -100.0% |
| Q4 2020 | $1,477,000 | -27.7% | 7,049 | -40.8% | 0.00% | -50.0% |
| Q3 2020 | $2,043,000 | +186.5% | 11,908 | +93.4% | 0.00% | +100.0% |
| Q2 2020 | $713,000 | -71.1% | 6,156 | -81.2% | 0.00% | -66.7% |
| Q1 2020 | $2,468,000 | -7.1% | 32,741 | +58.8% | 0.00% | +50.0% |
| Q4 2019 | $2,657,000 | +44.5% | 20,616 | -12.7% | 0.00% | 0.0% |
| Q3 2019 | $1,839,000 | +669.5% | 23,610 | +919.4% | 0.00% | – |
| Q2 2019 | $239,000 | +1891.7% | 2,316 | +712.6% | 0.00% | – |
| Q4 2018 | $12,000 | +71.4% | 285 | +105.0% | 0.00% | – |
| Q3 2018 | $7,000 | +16.7% | 139 | +7.8% | 0.00% | – |
| Q2 2018 | $6,000 | – | 129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |